Bethlehem, PA, United States

Saladax Biomedical

www.saladax.com
Bethlehem, PA, United States
SEARCH FILTERS
Time filter
Source Type

Patent
Saladax Biomedical | Date: 2013-03-28

Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.


Patent
Saladax Biomedical | Date: 2011-02-02

Novel conjugates of 5-fluoro-uracil and novel 5-fluoro-uracil immunogens and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of 5-fluoro-uracil in biological fluids.


Patent
Saladax Biomedical | Date: 2014-05-22

Novel conjugates and immunogens derived from clozapine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of clozapine in biological fluids.


Patent
Saladax Biomedical | Date: 2011-05-04

Novel conjugates of 5-fluoro-uracil and novel 5-fluoro-uracil Immunogens and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of 5-fluoro-uracil in biological fluids.


Patent
Bristol Myers Squibb and Saladax Biomedical | Date: 2013-12-18

The present invention provides novel peptides, compositions, and methods for creating quantitative novel compositions, as well as methods for creating quantitative standards to calibrate analytes. These peptides, compositions, and methods enable the creation of standards and calibrators for analyzing analytes and measuring clinical biomarkers (e.g., Tau). Also provided are kits comprising the peptides or compositions described herein, for use in assays (e.g., sandwich immunoassays).


Patent
Saladax Biomedical | Date: 2013-03-28

Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.


Patent
Saladax Biomedical | Date: 2013-03-15

The present invention comprises novel analogs of gemcitabine and novel gemcitabine immunogens teased out of, i.e., derived from, the 5-hydroxy position of gemcitabine. The invention also comprises unique monoclonal antibodies generated using gemcitabine linked immunogens as well as unique conjugates and tracers which antibodies, conjugates, and tracers are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids.


Patent
Saladax Biomedical | Date: 2012-08-08

Novel conjugates and immunogens derived from vincristine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of vincristine in biological fluids.


Patent
Saladax Biomedical | Date: 2011-03-30

Novel conjugates of docetaxel and novel docetaxel immunogens derived from the 7 position of docetaxel are useful in immunoassays for the quantification and monitoring of docetaxel in biological fluids.


Patent
Saladax Biomedical | Date: 2013-04-30

Novel conjugates and immunogens derived from risperidone and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of risperidone and paliperidone in biological fluids.

Loading Saladax Biomedical collaborators
Loading Saladax Biomedical collaborators